Microdroplet Screening for Cytotoxic Agent Producers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for screening mutant prokaryotic cells to identify producers of cytotoxic agents, such as antibiotics and anticancer agents, are laborious, not suited for high-throughput screening, and face challenges with detecting low-concentration compounds and overcoming the growth advantage of 'cheater' mutants that are resistant to cytotoxic agents.
Innovation Solution
A method involving transposon mutagenesis and co-encapsulating mutant producer cells with target cells in microdroplets, where mutant producer cells outgrow target cells, allowing for enrichment and identification of cytotoxic agents through fluorescence-activated droplet sorting and subsequent DNA sequencing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional screening methods using pure strains in solid or liquid media are used, then cytotoxic agent production can be detected, but the screening process becomes laborious and cannot be applied to high-throughput screens
Solution Approach 1:
The invention segments the screening process by co-encapsulating individual producer cells with target cells in separate microdroplets. This creates thousands of independent mini-reactors that can be processed in parallel, enabling high-throughput screening while maintaining simple operation through automated droplet generation and analysis
Solution Approach 2:
The invention introduces microdroplets as an intermediary medium that contains both producer and target cells in a confined aqueous environment suspended in oil. This intermediary structure enables high-throughput processing while maintaining the biological interactions needed for cytotoxic agent detection
2Measurement precision
If mutant producer cells are screened in liquid media, then growth rates can be measured, but cytotoxic compounds are diluted and difficult to detect
Solution Approach 1:
By segmenting the culture into individual microdroplets, the invention concentrates cytotoxic compounds within each tiny aqueous compartment. This prevents dilution effects while still allowing growth rate measurements, thereby improving detection sensitivity without sacrificing quantitative information
Solution Approach 2:
The invention uses fluorescently labeled target cells that change their fluorescence signal based on viability. This optical indicator allows sensitive detection of cytotoxic effects without requiring high concentrations of the cytotoxic compounds themselves
3Reliability
If resistant mutants ('cheaters') are present in the culture, then they survive cytotoxic treatment, but they overgrow and mask the identification of active producers
Solution Approach 1:
The invention segments the population into isolated microdroplets, each containing one or few producer cells and target cells. This physical separation prevents cheater mutants from overgrowing and masking active producers, as each droplet's outcome reflects the behavior of its specific inhabitants rather than being dominated by resistant contaminants
Solution Approach 2:
The invention implements feedback by using the survival status of fluorescently labeled target cells within each microdroplet to identify successful producers. Droplets showing reduced target cell fluorescence provide positive feedback signals that indicate cytotoxic agent production, enabling reliable identification despite the presence of resistant mutants
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables sensitive detection of cytotoxic compounds without dilution effects and avoids the overgrowth of resistant mutants, facilitating the identification of active producers and the analysis of their cytotoxic activity in a high-throughput manner.
Implementation Method 1
the TnA comprises an outward-facing promoter (TnAP) capable of increasing transcription of a gene at or near its insertion site
Implementation Method 2
co-encapsulating individual members of the pool of step (b) with one or more target cells in microdroplets, the microdroplets comprising a volume of aqueous growth media suspended in an immiscible carrier liquid
Implementation Method 3
screening the library of microcultures of step (d) for microcultures in which target cells have been outgrown or overgrown to extinction by mutant producer cells
Data Source
AI summary
Describe is a method for screening mutant prokaryotic cells to identify producers of a cytotoxic agent active against a target cell, the method comprising the steps of: (a) providing cells of a producer prokaryotic species; (b) generating a pool of mutant producer cells by transposon mutagenesis of the cells of step (a) with an activating transposon (TnA), wherein the TnA comprises an outward-facing promoter (TnAP) capable of increasing transcription of a gene at or near its insertion site in the DNA of said producer cells; (c) co-encapsulating individual members of the pool of step (b) with one or more target cells in microdroplets, the microdroplets comprising a volume of aqueous growth media suspended in an immiscible carrier liquid, thereby generating a library of microdroplets each comprising a single mutant producer cell and one or more target cell(s); (d) incubating the microdroplet library of step (c) under conditions suitable for co-culture of the single mutant producer cell and target cell(s) to produce a library of microcultures, whereby mutant producer cells producing a cytotoxic agent active against the target cell(s) outgrow target cells in each microculture; and (e) screening the library of microcultures of step (d) for microcultures in which target cells have been outgrown or overgrown to extinction by mutant producer cells.